Compugen cuts workforce by 35%

Compugen will reduce headcount by 35 (35%), with cuts coming primarily from R&D.

Compugen Ltd. (NASDAQ:CGEN) said the moves will extend its cash runway through mid-2020 and allow it to fund an expansion study of COM701, which is in Phase I testing for solid tumors...